In 2006, scientists participating to the Human Liver Proteome Project (HLPP) launched by the Human Proteome Organisation (HUPO) convened on two occasions to present and discuss their progress. A workshop was held over two days in May in Bilbao, Spain, and a brief 3-hour meeting was held in October in conjunction with the 5 th HUPO World Congress in Long Beach, California. Highlights included progress on the construction of the human normal liver proteome expression profile and of subcellular proteomes, establishment of a liver ORFeome bank and of a liver antibody bank, identifications of protein-protein interaction maps in the liver, application of a robust strategy for quantitative proteomics and the characterization of fatty liver diseases using mouse models.
The scientific objectives of HLPP are to characterize the proteome of the healthy human liver (expression profiling, cellular localization, post-translational modifications, protein-protein interactions) and to develop tools for its study (sample banking, ORFeome, antibodies). The information and tools that are generated by this international effort will be available to the scientific community with the hope that they will help understand, diagnose and treat liver diseases more effectively.
At the 2005 HLPP workshop held at the Airlie Center, USA, initial targets for HLPP were identified, as follows: 1-identification of 5,000 individual proteins in the normal human liver; 2-availability of antibodies against these 5,000 proteins; 3-determination of the presence of these 5,000 proteins in plasma. The aim of these targets is to generate sufficient knowledge of the normal liver and resources to allow the study of liver diseases and biomarker discovery. As 
